Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline-Levofloxacin vs Standard vs Amoxicillin-Levofloxacin for H. pylori
NCT05850117Unknown
- Sponsor
- Kaohsiung Medical University
- Start
- Feb 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levofloxacin in Helicobacter pylori infection (3 arms), sponsored by Kaohsiung Medical University. Primary endpoint: Rate of Helicobacter pylori eradication. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05850117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05850117.